20.5
Monopar Therapeutics
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
13.2
FY23:
7.33
FY24:
60.3
FY25:
140
(positive)
millions USD
FY21:
0
FY22:
0.06
FY23:
0.01
FY24:
0
FY25:
0.25
Total assets
Change from FY21 to FY25
millions USD
FY21:
20.5
FY22:
13.2
FY23:
7.35
FY24:
60.3
FY25:
141
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.58
FY22:
3.13
FY23:
1.76
FY24:
5.25
FY25:
2.74
(negative)
millions USD
FY21:
0
FY22:
0.01
FY23:
0
FY24:
0
FY25:
0.15
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.9
FY22:
10.1
FY23:
5.59
FY24:
55.0
FY25:
138
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
20.5
FY22:
13.2
FY23:
7.35
FY24:
60.3
FY25:
141
All amounts in millions USD